The Effect of Inhaled PUL-042 on Rhinovirus-induced Symptoms in Smokers With GOLD Stage 0 COPD
Clinical trial NCT03794557 · COMPLETED
Trial details
- NCT number
- NCT03794557
- Sponsor
- Pulmotect, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2020-12-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.